Resources

Spare parts for medical devices are crucial to maintaining uninterrupted service delivery in health care facilities. However, the public procurement of spare parts for medical devices is constrained by reactive and ad hoc purchasing decisions, often due to a lack of system-wide historical data on what spare parts are needed, in what quantities, and when. Without a data-driven, coordinated procurement strategy, purchasing decisions remain fragmented and inconsistent, limiting the ability to achieve economies of scale, ensure quality, or maintain timely availability of spare parts across the health system.To address this challenge, PATH developed a spare parts quantification and costing tool by engaging biomedical engineers in Kenya to build consensus around a standardized list of essential spare parts and the estimated annual frequency of use. The tool equips budget managers at health facilities and within county governments and the national Ministry of Health with more accurate system-wide estimates of annual spare parts demand and costs.

The Gates Foundation-funded project, MACEPA has long-standing relationships with National Malaria Programs, providing data analytics and modeling support to aid in data-driven decision-making. In 2024, MACEPA began a two-year fellowship program supporting individuals living in malaria-endemic countries to strengthen their data skills to support National Malaria Programs beyond their fellowship.

I-LEAD is an immersive, problem-solving set of interactive activities that engages participants in generating and sharing knowledge and developing skills needed to facilitate the successful implementation of an effective and sustainable national digital health ecosystem. The I-LEAD workshop facilitates the initial phases of a multistakeholder, multisectoral, and enterprise approach to the ongoing operationalization of effective and sustainable national digital health systems. I-LEAD enhances participants’ capacity to develop strategies and approaches to address essential informatics problems their countries face, related to: 1) effective digital health governance and leadership; 2) development of a skilled informatics workforce; and 3) the meaningful design, development, implementation, and evaluation of health information systems.As PEPFAR transitions its programs to host governments, the I-LEAD program provides a template for countries to systematically and collaboratively address complex program ownership and sustainability challenges.The I-LEAD curriculumThis Adaptable I-LEAD curriculum provides a comprehensive, customizable capacity-strengthening package designed to support governments and implementing partners, including national and regional health informatics associations, in adopting and implementing the I-LEAD program independently. This curriculum is designed to support individual countries in convening the right stakeholders and conducting all necessary preparations for a successful and productive workshop. The curriculum emphasizes not just the activities that happen during the in-person workshop but also the necessary pre-work for all participants to come prepared to collaborate meaningfully and make key decisions.Specifically, the curriculum includes the I-LEAD technical course content, an implementation guide to support the entire process, from initial engagement and workshop logistics to post-course evaluation, as well as facilitation guides aimed at strengthening the capacity of course facilitators. It also includes a localization toolkit to guide national adaptation.

This is a new position paper highlighting three ways that countries and other stakeholders can invest better in NCDs to ensure equitable access to care and commodities, especially during this turbulent time in global health financing.The position piece calls for stakeholders to focus on three priorities:Spend less on products that make us sick and spend more on systems to keep us healthy.Cut out inefficiencies across the supply chain to save lives, money, and time delivering NCD medicines to everyone who needs them.Track NCD spending from budget to real-world benefit to guarantee better decisions and better results.

This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.